• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶抑制剂对骨骼肌的影响。

Effects of ACE inhibitors on skeletal muscle.

作者信息

Onder Graziano, Vedova Cecilia Della, Pahor Marco

机构信息

Centro Medicina dell'Invecchiamento, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168, Rome - Italy.

出版信息

Curr Pharm Des. 2006;12(16):2057-64. doi: 10.2174/138161206777442137.

DOI:10.2174/138161206777442137
PMID:16787247
Abstract

Angiotensin-converting enzyme (ACE) inhibitors reduce morbidity, mortality, hospital admissions, and decline in physical function and exercise capacity in congestive heart failure (CHF) patients. These therapeutic effects are attributed primarily to beneficial cardiovascular actions of these drugs. However, it has been suggested that ACE inhibitor-induced positive effects may also be mediated by direct action on the skeletal muscle. In particular, two recently published observational studies documented that among hypertensive subjects free of CHF, treatment with ACE inhibitors was associated with better performance and muscular outcomes and genetic studies also support the hypothesis that the ACE system may be involved in physical performance and skeletal muscle function. Effects on the skeletal muscle are probably mediated by mechanical, metabolic, anti-inflammatory, nutritional, neurological and angiogenetic actions of these drugs. These studies may have major public health implications for older adults, as consequence of the fact that, in this population, gradual loss of muscle mass and muscle strength can play a key role in the onset and progression of disability. Therefore, if findings of observational studies will be later confirmed in randomized controlled trials, ACE inhibitors could represent an effective intervention to prevent physical decline in the elderly, leading to greater autonomy in this growing population.

摘要

血管紧张素转换酶(ACE)抑制剂可降低充血性心力衰竭(CHF)患者的发病率、死亡率、住院率,并减缓其身体功能和运动能力的衰退。这些治疗效果主要归因于这些药物有益的心血管作用。然而,有人提出,ACE抑制剂产生的积极效果也可能是通过对骨骼肌的直接作用介导的。特别是,最近发表的两项观察性研究表明,在没有CHF的高血压受试者中,使用ACE抑制剂治疗与更好的身体表现和肌肉结局相关,并且基因研究也支持ACE系统可能参与身体表现和骨骼肌功能的假说。这些药物对骨骼肌的影响可能是通过其机械、代谢、抗炎、营养、神经和血管生成作用介导的。这些研究可能对老年人具有重大的公共卫生意义,因为在这一人群中,肌肉质量和肌肉力量的逐渐丧失可能在残疾的发生和发展中起关键作用。因此,如果观察性研究的结果随后在随机对照试验中得到证实,ACE抑制剂可能代表一种有效的干预措施,以防止老年人身体机能下降,从而使这一不断增长的人群获得更大的自主性。

相似文献

1
Effects of ACE inhibitors on skeletal muscle.血管紧张素转换酶抑制剂对骨骼肌的影响。
Curr Pharm Des. 2006;12(16):2057-64. doi: 10.2174/138161206777442137.
2
Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition.通过抑制血管紧张素转换酶(ACE)调节代谢控制。
J Cell Physiol. 2003 Jul;196(1):171-9. doi: 10.1002/jcp.10294.
3
Angiotensin-converting enzyme gene expression in skeletal muscle in patients with chronic heart failure.慢性心力衰竭患者骨骼肌中血管紧张素转换酶基因的表达
J Card Fail. 1998 Sep;4(3):185-91. doi: 10.1016/s1071-9164(98)80005-5.
4
Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).血管紧张素转换酶抑制剂通过降低结缔组织生长因子(CTGF/CCN-2)的表达和活性来减少肌营养不良小鼠的骨骼肌纤维化。
Cell Tissue Res. 2013 Jul;353(1):173-87. doi: 10.1007/s00441-013-1642-6. Epub 2013 May 15.
5
Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats?血管紧张素转换酶抑制是否能增强大鼠的耐力表现和肌肉能量代谢?
J Appl Physiol (1985). 2004 Jan;96(1):59-64. doi: 10.1152/japplphysiol.00323.2003. Epub 2003 Aug 29.
6
Impaired skeletal muscle performance in the early stage of cardiac pressure overload in rabbits: beneficial effects of angiotensin-converting enzyme inhibition.
J Pharmacol Exp Ther. 1999 Oct;291(1):70-5.
7
Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study.血管紧张素转换酶抑制剂的使用与老年女性肌肉力量和身体功能的关系:一项观察性研究。
Lancet. 2002 Mar 16;359(9310):926-30. doi: 10.1016/s0140-6736(02)08024-8.
8
Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.血管紧张素转换酶基因插入/缺失多态性对心力衰竭患者血管紧张素转换酶抑制剂反应的影响。
J Cardiovasc Pharmacol. 1998 Dec;32(6):988-94. doi: 10.1097/00005344-199812000-00017.
9
Decreased muscle ACE activity enhances functional response to endurance training in rats, without change in muscle oxidative capacity or contractile phenotype.肌肉中血管紧张素转换酶(ACE)活性降低可增强大鼠对耐力训练的功能反应,而肌肉氧化能力或收缩表型并无变化。
J Appl Physiol (1985). 2009 Jul;107(1):346-53. doi: 10.1152/japplphysiol.91443.2008. Epub 2009 Apr 30.
10
Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload.血管紧张素转换酶基因型影响人类骨骼肌对功能性超负荷的反应。
Exp Physiol. 2000 Sep;85(5):575-9.

引用本文的文献

1
Capsulolabral Adhesions After Hip Arthroscopy for the Treatment of Femoroacetabular Impingement: Strategies During Rehabilitation and Return to Sport to Reduce the Risk of Revision.髋关节镜治疗股骨髋臼撞击症后关节盂唇粘连:康复及恢复运动期间降低翻修风险的策略
Arthrosc Sports Med Rehabil. 2022 Jan 28;4(1):e255-e262. doi: 10.1016/j.asmr.2021.10.031. eCollection 2022 Jan.
2
Effects of Functional Training on Sarcopenia in Elderly Women in the Presence or Absence of ACE Inhibitors.功能性训练对有或无 ACE 抑制剂的老年女性肌少症的影响。
Int J Environ Res Public Health. 2021 Jun 19;18(12):6594. doi: 10.3390/ijerph18126594.
3
Effect of Antihypertensive and Statin Medication Use on Muscle Performance in Community-Dwelling Older Adults Performing Strength Training.
抗高血压和他汀类药物的使用对进行力量训练的社区居住老年人肌肉性能的影响。
Drugs Aging. 2021 Mar;38(3):253-263. doi: 10.1007/s40266-020-00831-5. Epub 2021 Feb 5.
4
The role of the cell-matrix interface in aging and its interaction with the renin-angiotensin system in the aged vasculature.细胞-基质界面在衰老中的作用及其与老年血管中肾素-血管紧张素系统的相互作用。
Mech Ageing Dev. 2019 Jan;177:66-73. doi: 10.1016/j.mad.2018.04.002. Epub 2018 Apr 4.
5
Angiotensin-Converting Enzyme Inhibitors and Parameters of Sarcopenia: Relation to Muscle Mass, Strength and Function: Data from the Berlin Aging Study-II (BASE-II).血管紧张素转换酶抑制剂与肌肉减少症参数:与肌肉质量、力量和功能的关系:来自柏林衰老研究-II(BASE-II)的数据。
Drugs Aging. 2016 Nov;33(11):829-837. doi: 10.1007/s40266-016-0396-8.
6
Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl₄-Induced Skeletal Muscle Injury.氯沙坦,血管紧张素 II 型 1 型受体拮抗剂,对四氯化碳诱导的骨骼肌损伤的治疗作用。
Int J Mol Sci. 2016 Feb 8;17(2):227. doi: 10.3390/ijms17020227.
7
Reexamining the Effect of Antihypertensive Medications on Falls in Old Age.重新审视抗高血压药物对老年人跌倒的影响。
Hypertension. 2015 Jul;66(1):183-9. doi: 10.1161/HYPERTENSIONAHA.115.05513. Epub 2015 May 4.
8
Mechanisms governing the health and performance benefits of exercise.运动对健康和体能有益的作用机制。
Br J Pharmacol. 2013 Nov;170(6):1153-66. doi: 10.1111/bph.12399.
9
Cellular mechanisms of tissue fibrosis. 4. Structural and functional consequences of skeletal muscle fibrosis.细胞组织纤维化的机制。4. 骨骼肌纤维化的结构和功能后果。
Am J Physiol Cell Physiol. 2013 Aug 1;305(3):C241-52. doi: 10.1152/ajpcell.00173.2013. Epub 2013 Jun 12.
10
Sarcopenia: pharmacology of today and tomorrow.肌肉减少症:今日与明日的药理学。
J Pharmacol Exp Ther. 2012 Dec;343(3):540-6. doi: 10.1124/jpet.112.191759. Epub 2012 Aug 28.